These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26305685)

  • 41. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Significance of Early Repolarization in Long QT Syndrome.
    Sugrue A; Rohatgi RK; Bos M; Vaidya VR; Asirvatham SJ; Noseworthy PA; Ackerman MJ
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1238-1244. PubMed ID: 30236400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome.
    Sabir IN; Li LM; Jones VJ; Goddard CA; Grace AA; Huang CL
    Pflugers Arch; 2008 Jan; 455(4):637-51. PubMed ID: 17805561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inherited arrhythmic disorders: long QT and Brugada syndromes.
    Nader A; Massumi A; Cheng J; Razavi M
    Tex Heart Inst J; 2007; 34(1):67-75. PubMed ID: 17420796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing.
    Pablo Flórez J; García D; Valverde I; Rubín J; Pérez D; González-Vasserot M; Reguero J; María de la Hera J; Avanzas P; Gómez J; Coto E; Morís C; Calvo D
    Europace; 2018 Jun; 20(FI1):f64-f71. PubMed ID: 29309564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
    Lehtonen A; Fodstad H; Laitinen-Forsblom P; Toivonen L; Kontula K; Swan H
    Heart Rhythm; 2007 May; 4(5):603-7. PubMed ID: 17467628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
    Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
    Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol.
    Somberg JC; Preston RA; Ranade V; Molnar J
    Cardiology; 2010; 116(3):219-25. PubMed ID: 20693799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
    Turker I; Ai T; Itoh H; Horie M
    Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Arrhythmias in pregnancy. How and when to treat?].
    Flores JR; Márquez MF
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-24-S2-31. PubMed ID: 17972373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of electrocardiographic time intervals and QT rate dependence in hypertrophic cardiomyopathy.
    Robyns T; Nuyens D; Lu HR; Gallacher DJ; Vandenberk B; Garweg C; Ector J; Pagourelias E; Van Cleemput J; Janssens S; Willems R
    J Electrocardiol; 2018; 51(6):1077-1083. PubMed ID: 30497734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of Electrocardiographic Repolarization Parameters During Antiandrogen Therapy in Patients with Prostate Cancer and Hypogonadism.
    Gheorghe ACD; Ciobanu A; Hodorogea AS; Radavoi GD; Jinga V; Nanea IT; Gheorghe GS
    Cardiovasc Toxicol; 2020 Aug; 20(4):390-400. PubMed ID: 32152959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.
    Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL
    Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent supplement of estradiol and progesterone reduces the cardiac sensitivity to D,L-sotalol-induced arrhythmias in ovariectomized rabbits.
    Cheng J; Su D; Ma X; Li H
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):208-14. PubMed ID: 21875897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
    Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
    Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An update on risk factors for drug-induced arrhythmias.
    Vlachos K; Georgopoulos S; Efremidis M; Sideris A; Letsas KP
    Expert Rev Clin Pharmacol; 2016; 9(1):117-27. PubMed ID: 26460585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
    van Opstal JM; Schoenmakers M; Verduyn SC; de Groot SH; Leunissen JD; van Der Hulst FF; Molenschot MM; Wellens HJ; Vos MA
    Circulation; 2001 Nov; 104(22):2722-7. PubMed ID: 11723026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.
    Tokioka K; Kusano KF; Morita H; Miura D; Nishii N; Nagase S; Nakamura K; Kohno K; Ito H; Ohe T
    J Am Coll Cardiol; 2014 May; 63(20):2131-2138. PubMed ID: 24703917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.